CC SEC Filing News — The Chemours Company

Latest SEC filings for The Chemours Company (CC) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-01.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies seg…
Sector: Basic Materials Industry: Specialty Chemicals Market Cap: $1.9B CIK: 1627223
20
Total Filings
7
Bullish Classifications
0
Bearish Classifications
15
Insider Transactions
4
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for CC currently lean bullish. Of the 20 displayed SEC filing records, 7 carry bullish classifications versus 0 bearish classifications. These labels summarize filing attributes; they are not recommendations, probabilities, or evidence of future price direction. There were 15 insider transactions (Form 4) in this period.
CC Filing Activity Snapshot 2026-06-24 — 2026-10-01
Insider Transactions (Form 4)
7 buys vs 0 sells
Net insider buying in this period — more purchases than sales reported.
Largest Form 144 Filing
$203.1K
Cowan Alister (Director) · 2026-08-11
13,000 shares · Form 4
Insider Transactions 15 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 15 filings in this group are Form 4s for The Chemours Company.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 15 insider filings shown, the breakdown is 7 open-market purchase, 6 tax withholding and 2 compensation award. 7 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market purchase ×7
The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Tax withholding ×6
Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.
Compensation award ×2
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Compensation award Tax / Compensation Filing 2026-10-01

CC insider Form 4 filed for equity award, exercise, or tax withholding

MATHER COURTNEY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Deferred Stock Units 2,118 $13.57 $28.7K
Filing: Form 4 (Insider Transaction) Insider: MATHER COURTNEY (Director)
Form 4 Tax withholding Tax / Compensation Filing 2026-08-13

CC insider Form 4 filed for equity award, exercise, or tax withholding

Will David (Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 2,426 $15.24 $37.0K
Filing: Form 4 (Insider Transaction) Insider: Will David (Chief Accounting Officer) Shares: 2,426
Form 4 Open-market purchase Insider Buying 2026-08-13

CC insider Familiar Calderon Gerardo (See Remarks) bought 1,935 shares (~$30.1K)

Familiar Calderon Gerardo, listed as See Remarks at Chemours Co, reported an open-market purchase of 1,935 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 1,935 $15.53 $30.1K
Filing: Form 4 (Insider Transaction) Insider: Familiar Calderon Gerardo (See Remarks) Shares: 1,935 Est. Value: $30.1K
Form 4 Open-market purchase Insider Buying 2026-08-13

CC insider Dignam Denise (Director, Chief Executive Officer) bought 3,378 shares (~$50.5K)

Dignam Denise, listed as Director, Chief Executive Officer at Chemours Co, reported an open-market purchase of 3,378 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 3,378 $14.95 $50.5K
Filing: Form 4 (Insider Transaction) Insider: Dignam Denise (Director, Chief Executive Officer) Shares: 3,378 Est. Value: $50.5K
Form 4 Open-market purchase Insider Buying 2026-08-11

CC insider Cowan Alister (Director) bought 13,000 shares (~$203.1K)

Cowan Alister, listed as Director at Chemours Co, reported an open-market purchase of 13,000 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 13,000 $15.62 $203.1K
Filing: Form 4 (Insider Transaction) Insider: Cowan Alister (Director) Shares: 13,000 Est. Value: $203.1K
Form 4 Open-market purchase Insider Buying 2026-08-11

CC insider Foley Michael Robert (See Remarks) bought 1,934 shares (~$30.0K)

Foley Michael Robert, listed as See Remarks at Chemours Co, reported an open-market purchase of 1,934 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 1,934 $15.51 $30.0K
Filing: Form 4 (Insider Transaction) Insider: Foley Michael Robert (See Remarks) Shares: 1,934 Est. Value: $30.0K
Form 4 Open-market purchase Insider Buying 2026-08-11

CC insider Martinko Joseph T. (See Remarks) bought 1,939 shares (~$30.0K)

Martinko Joseph T., listed as See Remarks at Chemours Co, reported an open-market purchase of 1,939 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 1,939 $15.47 $30.0K
Filing: Form 4 (Insider Transaction) Insider: Martinko Joseph T. (See Remarks) Shares: 1,939 Est. Value: $30.0K
Form 4 Open-market purchase Insider Buying 2026-08-11

CC insider CRANSTON MARY B (Director) bought 6,000 shares (~$95.0K)

CRANSTON MARY B, listed as Director at Chemours Co, reported an open-market purchase of 6,000 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 6,000 $15.82 $95.0K
Filing: Form 4 (Insider Transaction) Insider: CRANSTON MARY B (Director) Shares: 6,000 Est. Value: $95.0K
Form 4 Open-market purchase Insider Buying 2026-08-10

CC insider HOSTETTER SHANE (Chief Financial Officer) bought 3,350 shares (~$50.0K)

HOSTETTER SHANE, listed as Chief Financial Officer at Chemours Co, reported an open-market purchase of 3,350 CC shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code Nature Shares Price Value
P Open-market purchase 3,350 $14.94 $50.0K
Filing: Form 4 (Insider Transaction) Insider: HOSTETTER SHANE (Chief Financial Officer) Shares: 3,350 Est. Value: $50.0K
Form 4 Tax withholding Tax / Compensation Filing 2026-08-10

CC insider Form 4 filed for equity award, exercise, or tax withholding

HOSTETTER SHANE (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 3,087 $15.11 $46.6K
Filing: Form 4 (Insider Transaction) Insider: HOSTETTER SHANE (Chief Financial Officer) Shares: 3,087
Form 4 Tax withholding Tax / Compensation Filing 2026-08-04

CC insider Form 4 filed for equity award, exercise, or tax withholding

Familiar Calderon Gerardo (See Remarks) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 943 $16.61 $15.7K
Filing: Form 4 (Insider Transaction) Insider: Familiar Calderon Gerardo (See Remarks) Shares: 943
Form 4 Tax withholding Tax / Compensation Filing 2026-08-04

CC insider Form 4 filed for equity award, exercise, or tax withholding

Martinko Joseph T. (See Remarks) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 663 $16.61 $11.0K
Filing: Form 4 (Insider Transaction) Insider: Martinko Joseph T. (See Remarks) Shares: 663
Form 4 Tax withholding Tax / Compensation Filing 2026-08-04

CC insider Form 4 filed for equity award, exercise, or tax withholding

Dignam Denise (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 477 $16.61 $7.9K
Filing: Form 4 (Insider Transaction) Insider: Dignam Denise (Director, Chief Executive Officer) Shares: 477
Form 4 Tax withholding Tax / Compensation Filing 2026-08-04

CC insider Form 4 filed for equity award, exercise, or tax withholding

Wellman Kristine M (SVP, GC & Corp. Secretary) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 391 $16.61 $6.5K
Filing: Form 4 (Insider Transaction) Insider: Wellman Kristine M (SVP, GC & Corp. Secretary) Shares: 391
Form 4 Compensation award Tax / Compensation Filing 2026-07-01

CC insider Form 4 filed for equity award, exercise, or tax withholding

MATHER COURTNEY (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Deferred Stock Units 1,401 $20.52 $28.7K
Filing: Form 4 (Insider Transaction) Insider: MATHER COURTNEY (Director)
Material Events 4 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 4 in this period for The Chemours Company. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-10

CC filed 8-K — material company event

Chemours Co filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-09-09

CC filed 8-K — material company event

Chemours Co filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-04

CC filed 8-K — material company event

Chemours Co filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-06-24

CC filed 8-K — material company event

Chemours Co filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for The Chemours Company.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-05

CC filed Quarterly Report (10-Q)

Chemours Co filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify The Chemours Company's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CC. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CC SEC Filings

More Tools for CC

Want deeper CC analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CC stock analysis page.

CC Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer